ArticleJEADV clinical practice2026
Compliance of Dermatology Screening Visits Among Patients With Skin Cancer-Predisposing Pathogenic Variants.
Article in JEADV clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Advances in genetic testing allow clinicians to identify patients with pathogenic variants that increase their risk of skin cancer. Whether this information results in more frequent dermatology screening visits as recommended by the National Comprehensive Cancer Network (NCCN) guidelines is unknown. Objectives: Our objective was to evaluate compliance with NCCN dermatology screening guidelines among patients with skin cancer-predisposing pathogenic variants and to determine whether visiting a Hereditary Cancer Clinic (HCC) would improve adherence to skin cancer screening. Methods: We employed a retrospective observational cross-sectional design in a consecutive sample of 230 patients with pathogenic variants in Results: Overall compliance with dermatology visits improved from 11.1% before HCC visits to 37% after visiting the HCC ( Conclusions: HCC visits and personal and family history of skin cancer were associated with improved adherence to NCCN dermatology screening guidelines among patients with skin cancer-predisposing variants. Thus, dedicated HCCs could improve early detection and intervention of premalignant and malignant skin lesions. Additional studies that include a larger number of minority patients are required to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.